Amgen Inc. (BKK:AMGN06)

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of THB 5.80 trillion. The enterprise value is 7.22 trillion.

Market Cap	5.80T
Enterprise Value	7.22T

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	79.71%
Float	537.12M

Valuation Ratios

The trailing PE ratio is 25.50 and the forward PE ratio is 16.20.

PE Ratio	25.50
Forward PE	16.20
PS Ratio	4.97
PB Ratio	18.57
P/TBV Ratio	n/a
P/FCF Ratio	15.48
P/OCF Ratio	13.61
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.74, with an EV/FCF ratio of 19.28.

EV / Earnings	31.76
EV / Sales	6.37
EV / EBITDA	13.74
EV / EBIT	20.54
EV / FCF	19.28

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 5.67.

Current Ratio	1.28
Quick Ratio	0.82
Debt / Equity	5.67
Debt / EBITDA	3.27
Debt / FCF	4.73
Interest Coverage	3.32

Financial Efficiency

Return on equity (ROE) is 81.71% and return on invested capital (ROIC) is 17.18%.

Return on Equity (ROE)	81.71%
Return on Assets (ROA)	7.71%
Return on Invested Capital (ROIC)	17.18%
Return on Capital Employed (ROCE)	16.33%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	41.72M
Profits Per Employee	8.12M
Employee Count	28,000
Asset Turnover	0.40
Inventory Turnover	1.57

Taxes

In the past 12 months, Amgen has paid 40.24 billion in taxes.

Income Tax	40.24B
Effective Tax Rate	15.03%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	4,090

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.80

Income Statement

In the last 12 months, Amgen had revenue of THB 1.17 trillion and earned 227.48 billion in profits. Earnings per share was 420.01.

Revenue	1.17T
Gross Profit	818.28B
Operating Income	362.41B
Pretax Income	267.72B
Net Income	227.48B
EBITDA	535.20B
EBIT	362.41B
Earnings Per Share (EPS)	420.01

Balance Sheet

The company has 306.72 billion in cash and 1.77 trillion in debt, with a net cash position of -1,465.94 billion.

Cash & Cash Equivalents	306.72B
Total Debt	1.77T
Net Cash	-1,465.94B
Net Cash Per Share	n/a
Equity (Book Value)	312.37B
Book Value Per Share	580.07
Working Capital	197.90B

Cash Flow

In the last 12 months, operating cash flow was 426.25 billion and capital expenditures -51.54 billion, giving a free cash flow of 374.72 billion.

Operating Cash Flow	426.25B
Capital Expenditures	-51.54B
Free Cash Flow	374.72B
FCF Per Share	n/a

Margins

Gross margin is 70.05%, with operating and profit margins of 31.02% and 19.47%.

Gross Margin	70.05%
Operating Margin	31.02%
Pretax Margin	22.92%
Profit Margin	19.47%
EBITDA Margin	45.82%
EBIT Margin	31.02%
FCF Margin	32.08%

Dividends & Yields

Amgen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	72.03%
Buyback Yield	-0.28%
Shareholder Yield	-0.28%
Earnings Yield	3.92%
FCF Yield	6.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.69 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.69
Piotroski F-Score	7